AMICAS Rejects Rival Offer

Nasdaq-listed AMICAS, Inc. an image and information management solutions company, responded Merge Healthcare Inc.'s acquisition proposal. AMICAS Board of Directors has considered and publicly rejected Merge's acquisition proposal, and the company restated its support its previously agreed-upon deal to sell to Thoma Bravo for $217 million.

23 February 2010•6 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles